Xeris Biopharma Holdings Net Debt Growth & History (XERS)
Xeris Biopharma Holdings's net debt was $147.1M for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $147.1M | −$52.8M | −26.41% |
| 2024 | 2024-12-31 | $199.8M | $38.1M | +23.55% |
| 2023 | 2023-12-31 | $161.7M | $85.7M | +112.56% |
| 2022 | 2022-12-31 | $76.1M | $55.3M | +265.89% |
| 2021 | 2021-12-31 | $20.8M | −$28.6M | −57.92% |
| 2020 | 2020-12-31 | $49.4M | — | — |
Xeris Biopharma Holdings quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $167.7M | −$30.2M | −15.28% |
| Q1 2026 | 2026-03-31 | $146.8M | −$63.5M | −30.20% |
| Q4 2025 | 2025-12-31 | $147.1M | −$52.8M | −26.41% |
| Q3 2025 | 2025-09-30 | $166.1M | −$30.6M | −15.57% |
| Q2 2025 | 2025-06-30 | $197.9M | −$14.3M | −6.72% |
| Q1 2025 | 2025-03-31 | $210.3M | — | — |
| Q4 2024 | 2024-12-31 | $199.8M | $38.1M | +23.55% |
| Q3 2024 | 2024-09-30 | $196.7M | $14.9M | +8.18% |
| Q2 2024 | 2024-06-30 | $212.2M | — | — |
| Q4 2023 | 2023-12-31 | $161.7M | $85.7M | +112.56% |
| Q3 2023 | 2023-09-30 | $181.8M | $127.4M | +234.20% |
| Q4 2022 | 2022-12-31 | $76.1M | $55.3M | +265.89% |
| Q3 2022 | 2022-09-30 | $54.4M | $26.2M | +92.76% |
| Q2 2022 | 2022-06-30 | $42.7M | — | — |
| Q1 2022 | 2022-03-31 | $33.9M | — | — |
| Q4 2021 | 2021-12-31 | $20.8M | −$28.6M | −57.92% |
| Q3 2021 | 2021-09-30 | $28.2M | — | — |
| Q4 2020 | 2020-12-31 | $49.4M | — | — |
Xeris Biopharma Holdings net debt trends
Over the last five fiscal years, Xeris Biopharma Holdings's net debt increased from $49.4M to $147.1M, a change of $97.6M. The latest reported quarter, Q2 2026, shows $167.7M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings source filings ↗